Skip to content

Zoonotic Influenza Surveillance in Belgium

Active Surveillance of Influenza Virus Zoonotic Transmission Events: a Pilot Study in Belgium

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05827601
Acronym
ZOOIS
Enrollment
200
Registered
2023-04-25
Start date
2023-09-01
Completion date
2024-12-31
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza, Human

Brief summary

The project aims at implementing a more pro-active surveillance of potential transmission of influenza viruses to humans (zoonotic transmission). Clinical surveillance of influenza in humans and avian species is well organized and has been operating for decades, but currently there is no pro-active systematic surveillance of potential transmission of animal (avian or swine) influenza viruses to humans, only follow-up of people showing clinical symptoms. People working with potentially infected animals have the highest risk. Moreover, they can represent the first steps in a pandemic: if the virus adapts to humans, infected workers could potentially spread the virus to other people. Currently, highly pathogenic clade2.3.4.4b H5 avian influenza viruses are continuously circulating in wild birds in Belgium and the number of introduction in poultry farms has raised, increasing the contact opportunities with high viral concentrations. Several reports of suspected human infection have been made by different countries. In addition, the virus was detected in sick non-human mammals. The large circulation in wild birds thus represents an increase risk of spill-over to mammalian species, including humans, (by contact directly with wild birds, or via outbreaks in poultry). This increased opportunity for accidental spillover to new host species increases the chances for the avian virus to adapt to mammals, including humans. Likewise, there have also been an increased number of human cases of swine influenza reported by several European countries. A pro-active surveillance aiming at also detecting asymptomatic infections would allow an early detection of transmission that could help to prevent a new pandemic. As a piloting approach during this specific project, some dedicated sentinel networks among at-risk workers will be initiated: people in poultry farms involved with the management of outbreaks of highly pathogenic avian influenza; people working at bird (or more generally wild life) rehabilitation centres or poultry farms; veterinarians working in pig farms/slaughterhouses.

Interventions

DIAGNOSTIC_TESTrespiratory specimen

participants will perform self-sampling with a nasopharyngeal swab

DIAGNOSTIC_TESTserum

participants will be invited to get a blood sample taken by a general practitioner or to perform a self sampling of capillary blood

Sponsors

Sciensano
CollaboratorOTHER_GOV
Belgian Federal Public Service, Food Chain Safety and Environment
CollaboratorOTHER_GOV
Agentschap Zorg en Gezondheid
CollaboratorUNKNOWN
Cyril Barbezange
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* worker or volunteer of one of the targeted groups at one of the selected sites and accepting to take part in the study * to have regular contacts with animals within job/activity framework * being committed to take the regular samples

Exclusion criteria

\- people who had a broken nose might have difficulties to perform self-swabbing

Design outcomes

Primary

MeasureTime frameDescription
Number of sentinel participants positive for a non-seasonal influenza virusevery 2 weeks through study completion (December 2024)result of RT-qPCR test to detect and characterize non-influenza viruses
Number of outbreak participants positive for a non-seasonal influenza virusevery 2 days during 2 weeks after enrollmentresult of RT-qPCR test to detect and characterize non-influenza viruses

Secondary

MeasureTime frameDescription
Number of outbreak participants with seroconversion against a non-seasonal influenza virusat enrollment and about 4 weeks afterresult of inhibition of haemagglutination or seroneutralisation assay

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026